Efficacy and safety of FLOT combined with apatinib and sintilimab as a neoadjuvant therapy regimen for locally advanced gastric or gastroesophageal junction adenocarcinoma: An open-lable, single-arm, phase II study

被引：1
|
作者：
Zhou, H. [1 ]
Long, B. [2 ]
Yu, Z. [3 ]
Zhu, J. [2 ]
Yang, H. [4 ]
Zhang, W. [3 ]
Guan, X. [5 ]
Zhang, G. [2 ]
Li, L. [2 ]
Luo, C. [2 ]
Cao, H. [2 ]
Zhang, S. [2 ]
Chen, S. [2 ]
He, Q. [2 ]
Gan, S. [2 ]
Zhou, L. [2 ]
Jiang, X. [2 ]
Shi, W.
Huang, Z. [5 ]
Mao, J. [2 ]
Dong, C. [6 ]
Jiao, Z. [2 ]
机构：
[1] Gansu Prov Canc Hosp, Dept Abdominal Surg, Lanzhou, Peoples R China
[2] Lanzhou Univ Second Hosp, Dept Gen Surg, Lanzhou, Peoples R China
[3] Lanzhou Univ Second Hosp, Dept Radiol, Lanzhou, Peoples R China
[4] Lanzhou Univ Second Hosp, Cuiying Cent Lab, Lanzhou, Peoples R China
[5] Lanzhou Univ Second Hosp, Dept Gastroenterol, Lanzhou, Peoples R China
[6] Lanzhou Univ Second Hosp, Dept Pathol, Lanzhou, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.04.202
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-146
引用
收藏
页码：S66 / S67
页数：2
相关论文
共 50 条
  • [41] Camrelizumab combined with apatinib and S-1 as second-line treatment for patients with advanced gastric or gastroesophageal junction adenocarcinoma: a phase 2, single-arm, prospective study
    Jing, Chao
    Wang, Junyun
    Zhu, Mingyue
    Bai, Zhigang
    Zhao, Baoyi
    Zhang, Jun
    Yin, Jie
    Yang, Xiaobao
    Liu, Zongzhi
    Zhang, Zhongtao
    Deng, Wei
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2022, 71 (11) : 2597 - 2608
  • [42] Efficacy and safety of neoadjuvant chemoradiotherapy plus apatinib for patients with locally advanced, HER2-negative, Siewert's type II-III adenocarcinoma of esophagogastric junction: a single-arm, open-label, phase II trial
    Guo, Honghai
    Li, Yong
    Lin, Chi
    Cheng, Yunjie
    Zhang, Zhidong
    Wang, Dong
    Zhao, Xuefeng
    Liu, Yu
    Jing, Shaowu
    Yang, Peigang
    Tian, Yuan
    Liu, Yang
    Wang, Jun
    Zhao, Qun
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2021, 13 (08): : 9015 - 9023
  • [43] A single-arm study of apatinib plus neoadjuvant chemotherapy followed by resection in patients with locally advanced colorectal adenocarcinoma
    Zhang, T.
    Li, G.
    Zhang, A.
    ANNALS OF ONCOLOGY, 2021, 32 : S131 - S131
  • [44] Efficacy and safety of camrelizumab combined with FLOT versus FLOT alone as neoadjuvant therapy in patients with resectable locally advanced gastric and gastroesophageal junction adenocarcinoma who received D2 radical gastrectomy: Data update.
    Liu, Zimin
    Liu, Ning
    Zhou, Yanbing
    Niu, Zhaojian
    Jiang, Haitao
    Zhu, Yingqian
    Wang, Huiyun
    Li, Xiaoxiao
    Song, Shanai
    Liu, Xiaodong
    Li, Zequn
    Zhao, Shufen
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E16044 - E16044
  • [45] Tislelizumab combined with XELOX as a neoadjuvant therapy for locally advanced gastric and gastroesophageal junction adenocarcinomas: A prospective, phase II trial
    Zhou, Haikun
    Han, Tao
    Tuo, Lei
    Yang, Qingchuan
    Gao, Ruiqi
    Yu, Pengfei
    Wei, Jiangpeng
    Zhu, Changbin
    Wang, Jin
    Cheng, Peng
    Kang, Xiang
    Pi, Sihui
    Liu, Hui
    Pan, Xiaoxi
    Li, Xiaohua
    Ji, Gang
    CANCER RESEARCH, 2024, 84 (06)
  • [46] Phase II study of perioperative toripalimab in combination with FLOT in patients with locally advanced resectable gastric/gastroesophageal junction (GEJ) adenocarcinoma.
    Li, Hongli
    Deng, Jingyu
    Ge, Shaohua
    Zang, Fenglin
    Zhang, Le
    Ren, Peng
    Wang, Baogui
    Cao, Fuliang
    Deng, Ting
    Liu, Rui
    Ning, Tao
    Yang, Yuchong
    Bai, Ming
    Wang, Xia
    Ji, Zhi
    Duan, Jingjing
    Liu, Yong
    Zhou, Dejun
    Liang, Han
    Ba, Yi
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [47] Chemotherapy combined with cadonilimab (AK104) as neoadjuvant treatment for locally advanced gastric/gastro-oesophageal junction adenocarcinoma: study protocol for a single-arm, phase II clinical trial
    Zhang, Peng-Fei
    Zhang, Wei-Han
    Liu, Xi-Jiao
    He, Du
    Yang, Kun
    Gou, Hong-Feng
    Hu, Jian-Kun
    BMJ OPEN, 2024, 14 (12):
  • [48] Transcatheter arterial chemoembolization combined with apatinib and camrelizumab for unresectable advanced gastric or gastroesophageal junction cancer: a single-arm, single-center, retrospective study
    Wu, Kunpeng
    Li, Yahua
    Li, Zongming
    Zhou, Zihe
    Ge, Xiaoyong
    Li, Yifan
    Han, Xinwei
    Chen, Peng
    Ren, Kewei
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [49] The Efficacy and Safety of Anlotinib in Neoadjuvant Treatment of Locally Advanced Thyroid Cancer: A Single-Arm Phase II Clinical Trial
    Huang, Nai-si
    Wei, Wen-jun
    Xiang, Jun
    Chen, Jia-ying
    Guan, Qing
    Lu, Zhong-wu
    Ma, Ben
    Sun, Guo-hua
    Wang, Yu-long
    Ji, Qing-hai
    Wang, Yu
    THYROID, 2021, 31 (12) : 1808 - 1813
  • [50] Safety and efficacy of sintilimab combined with oxaliplatin/capecitabine as first-line treatment in patients with locally advanced or metastatic gastric/gastroesophageal junction adenocarcinoma in a phase Ib clinical trial
    Jiang, Haiping
    Zheng, Yulong
    Qian, Jiong
    Mao, Chenyu
    Xu, Xin
    Li, Ning
    Xiao, Cheng
    Wang, Huan
    Teng, Lisong
    Zhou, Hui
    Wang, Shuyan
    Zhu, Donglei
    Peng, Bo
    Shen, Lin
    Xu, Nong
    BMC CANCER, 2020, 20 (01)
12345